Next Article in Journal
Evolution from Covalent to Self-Assembled PAMAM-Based Dendrimers as Nanovectors for siRNA Delivery in Cancer by Coupled In Silico-Experimental Studies. Part I: Covalent siRNA Nanocarriers
Previous Article in Journal
Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium
Open AccessArticle

Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization

1
Pharmaceutical Technology Department, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang, Malaysia
2
Pharmaceutics Department, Dubai Pharmacy College for Girls, Dubai, UAE
3
Department of Pharmaceutical Engineering, Faculty of Engineering Technology, University Malaysia Pahang, Kuantan 26600, Pahang, Malaysia
4
Centre for Excellence for Advanced Research in Fluid flow (CARIFF), University Malaysia Pahang, Kuantan 26600, Pahang, Malaysia
*
Author to whom correspondence should be addressed.
Pharmaceutics 2019, 11(7), 350; https://doi.org/10.3390/pharmaceutics11070350
Received: 12 June 2019 / Revised: 9 July 2019 / Accepted: 11 July 2019 / Published: 18 July 2019
In the contemporary medical model world, the proniosomal system has been serving as a new drug delivery system that is considered to significantly enhance the bioavailability of drugs with low water solubility. The application of this system can improve the bioavailability of aceclofenac that is used for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The present study is intended to develop an optimized proniosomal aceclofenac formula by the use of different carriers. Aceclofenac proniosomes have been prepared by slurry method, and different carriers such as maltodextrin, mannitol, and glucose were tried. Prepared proniosomes characterized by differential scanning calorimetry (DSC) analysis and Fourier transform infrared (FTIR) analysis revealed the compatibility of the drug chosen with the ingredient added, powder X-ray diffractometry (XRD) confirmed the amorphous phase of the prepared proniosomes, and finally, the surfactant layer was observed by scanning electron microscopy (SEM). Aceclofenac physical state transformations were confirmed with all formulas but maltodextrin proniosomes exhibited solubility more than other formulations. HPLC method has been used to analyze the niosomes derived from proniosomes in terms of their entrapment capability and drug content. The obtained results revealed that aceclofenac proniosomes can be successfully prepared by using different carriers. View Full-Text
Keywords: aceclofenac; proniosomes; niosomes; carrier aceclofenac; proniosomes; niosomes; carrier
Show Figures

Figure 1

MDPI and ACS Style

Sammour, R.M.; Taher, M.; Chatterjee, B.; Shahiwala, A.; Mahmood, S. Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization. Pharmaceutics 2019, 11, 350.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop